Spots Global Cancer Trial Database for Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)
Official Title: Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) - Epidemiological and Molecular Pathological Aspects
Study ID: NCT01732432
Interventions
Study Description
Brief Summary: The purpose of this study is to determine whether a relationship exists between a previously established diagnosis of endometriosis and the consecutive risk of developing a clear cell or endometrioid ovarian carcinoma. All histopathological records since 1980 with these diagnoses (endometriosis, clear cell and endometrioid ovarian carcinoma) will be reviewed. Cancer registry data will be assessed to investigate differences in survival of women with endometriosis-associated ovarian carcinomas and those ovarian carcinoma patients without previous diagnosis of endometriosis.
Detailed Description:
Keywords
Eligibility
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Ellen Obermann, MD, Dr.
Affiliation: University Hospital Basel, University of Basel
Role: PRINCIPAL_INVESTIGATOR
Name: Ellen C Obermann, MD
Affiliation: Institute of Pathology, University Hospital Basel, University of Basel
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
